Lai Gang
Known title: Chief Executive OfficerCIK: 0002112995
Associated companies
Transaction History
| UPC | ▲ Buy | Grant | 12,610 | — | 5/7/2026 | View on chart |
| UPC | ▲ Buy | Grant | 71,890 | — | 5/7/2026 | View on chart |
| UPC | ▲ Buy | Grant | 12,610 | — | 5/7/2026 | View on chart |
| UPC | ▲ Buy | Grant | 71,890 | — | 5/7/2026 | View on chart |
We use analytics to understand how market-wall is used. No personal data is sold.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
UPC Files $200M Shelf Prospectus for Class A Shares
Universe Pharmaceuticals announced a prospectus for a $200 million mixed shelf offering, allowing 4.377 million Class A shares to be sold by existing shareholders. The filing gives the company flexibility to raise capital while giving shareholders an exit option. The move comes as several health‑care stocks, including UPC, moved in Tuesday’s after‑market session, which may influence short‑term trading activity.
UPC Files $200M Shelf Prospectus for Class A Shares. Universe Pharmaceuticals announced a prospectus for a $200 million mixed shelf offering, allowing 4.377 million Class A shares to be sold by existing shareholders. The filing gives the company flexibility to raise capital while giving shareholders an exit option. The move comes as several health‑care stocks, including UPC, moved in Tuesday’s after‑market session, which may influence short‑term trading activity.